Form 4: HRT Financial LP Acquires Shuttle Pharmaceuticals Stock

HRT Financial LP reports significant stock acquisitions in Shuttle Pharmaceuticals Holdings, Inc. on June 29th and June 30th, 2026.

Summary

• HRT Financial LP, a 10% owner of Shuttle Pharmaceuticals Holdings, Inc., has reported the acquisition of common stock.
• On June 29, 2026, HRT Financial LP acquired 25,836 shares at a price of $3.44 per share.
• Following this transaction, HRT Financial LP beneficially owned 71,842 shares.
• On June 30, 2026, an additional 6,755 shares were acquired at $3.23 per share.
• After the second transaction, HRT Financial LP's total beneficial ownership increased to 78,597 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates increased investment from a significant owner, but lacks broader financial performance data.

Positives

• HRT Financial LP, a significant stakeholder, has increased its beneficial ownership in Shuttle Pharmaceuticals Holdings, Inc.
• The acquisitions were made at prices below $4.00, potentially indicating a favorable entry point for the investor.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings from significant owners like HRT Financial LP can signal confidence or strategic adjustments in a company's stock. These transactions, particularly when they increase beneficial ownership, are closely watched by the market.

Stakeholder Impact

• Shareholders may view the increased stake by HRT Financial LP as a positive signal of confidence in the company's future prospects.
• The transactions do not appear to directly impact employees, customers, suppliers, or creditors based on the information provided.

Key Dates

Recommendation

The filing indicates increased beneficial ownership by a 10% owner, which is generally a positive signal. However, without accompanying financial performance data or strategic updates, it's prudent to hold and await further information rather than making a strong buy or sell decision.

Keywords

Shuttle Pharmaceuticals Holdings, SHPH, HRT Financial LP, Form 4, SEC Filing, Stock Acquisition, Beneficial Ownership, 10% Owner